Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Glenmark Pharmaceuticals Ltd.
NSE: GLENMARK
|
BSE: 532296
|
ISIN: INE935A01035
|
Industry: Pharmaceuticals
Board Meeting
|
Mid-range Performer
2030.7000
12.10
(
0.60
%)
NSE
Sep 25, 2025
15:31 PM
59.21% Gain from 52W Low
Volume:
1.1M
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Glenmark Pharmaceuticals Ltd.
30 May 2019
Board Meeting
2030.70
0.60%
Glenmark Pharma -4QFY19 Result Update
Hold:
Glenmark Pharmaceuticals Ltd.
by
Reliance Securities
Target: 580
Target
Reliance Securities
Glenmark Pharmaceuticals Ltd. has gained
20.65%
in the last 3 Months
More from Glenmark Pharmaceuticals Ltd.
Recommended
Market closes lower, HAL bags Rs 66,500 cr order for fighter jets
Trendlyne Marketwatch |
25 Sep 2025, 03:57PM
Indices at a glance: Biggest winners and losers over the past year
The Baseline |
25 Sep 2025, 12:17PM
Earnings Call Transcript - Q4FY20 for Glenmark Pharmaceuticals
|
29 Jun 2020